217 related articles for article (PubMed ID: 33381597)
1. MicroRNA-361-5p Inhibits Tumorigenesis and the EMT of HCC by Targeting Twist1.
Yin LC; Xiao G; Zhou R; Huang XP; Li NL; Tan CL; Xie FJ; Weng J; Liu LX
Biomed Res Int; 2020; 2020():8891876. PubMed ID: 33381597
[TBL] [Abstract][Full Text] [Related]
2. Twist1-related miR-26b-5p suppresses epithelial-mesenchymal transition, migration and invasion by targeting SMAD1 in hepatocellular carcinoma.
Wang Y; Sun B; Zhao X; Zhao N; Sun R; Zhu D; Zhang Y; Li Y; Gu Q; Dong X; Wang M; An J
Oncotarget; 2016 Apr; 7(17):24383-401. PubMed ID: 27027434
[TBL] [Abstract][Full Text] [Related]
3. CASC15 promotes epithelial to mesenchymal transition and facilitates malignancy of hepatocellular carcinoma cells by increasing TWIST1 gene expression via miR-33a-5p sponging.
Li Y; Chen G; Yan Y; Fan Q
Eur J Pharmacol; 2019 Oct; 860():172589. PubMed ID: 31401158
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-361-5p inhibits epithelial-to-mesenchymal transition of glioma cells through targeting Twist1.
Zhang X; Wei C; Li J; Liu J; Qu J
Oncol Rep; 2017 Mar; 37(3):1849-1856. PubMed ID: 28184914
[TBL] [Abstract][Full Text] [Related]
5. miR-139-5p inhibits epithelial-mesenchymal transition, migration and invasion of hepatocellular carcinoma cells by targeting ZEB1 and ZEB2.
Qiu G; Lin Y; Zhang H; Wu D
Biochem Biophys Res Commun; 2015 Jul; 463(3):315-21. PubMed ID: 26022123
[TBL] [Abstract][Full Text] [Related]
6. miR-27a-3p suppresses tumor metastasis and VM by down-regulating VE-cadherin expression and inhibiting EMT: an essential role for Twist-1 in HCC.
Zhao N; Sun H; Sun B; Zhu D; Zhao X; Wang Y; Gu Q; Dong X; Liu F; Zhang Y; Li X
Sci Rep; 2016 Mar; 6():23091. PubMed ID: 26980408
[TBL] [Abstract][Full Text] [Related]
7. Involvement of H19/miR-326 axis in hepatocellular carcinoma development through modulating TWIST1.
Wei LQ; Li L; Lu C; Liu J; Chen Y; Wu H
J Cell Physiol; 2019 Apr; 234(4):5153-5162. PubMed ID: 30362512
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA miR-509-3p inhibit metastasis and epithelial-mesenchymal transition in hepatocellular carcinoma.
Zhang H; Liu S; Chen L; Sheng Y; Luo W; Zhao G
Bioengineered; 2021 Dec; 12(1):2263-2273. PubMed ID: 34115554
[TBL] [Abstract][Full Text] [Related]
9. The long noncoding RNA AK002107 negatively modulates miR-140-5p and targets TGFBR1 to induce epithelial-mesenchymal transition in hepatocellular carcinoma.
Tang YH; He GL; Huang SZ; Zhong KB; Liao H; Cai L; Gao Y; Peng ZW; Fu SJ
Mol Oncol; 2019 May; 13(5):1296-1310. PubMed ID: 30943320
[TBL] [Abstract][Full Text] [Related]
10. miR-296-5p suppresses EMT of hepatocellular carcinoma via attenuating NRG1/ERBB2/ERBB3 signaling.
Shi DM; Li LX; Bian XY; Shi XJ; Lu LL; Zhou HX; Pan TJ; Zhou J; Fan J; Wu WZ
J Exp Clin Cancer Res; 2018 Nov; 37(1):294. PubMed ID: 30486894
[TBL] [Abstract][Full Text] [Related]
11. Downregulation of hsa_circ_0001681 suppresses epithelial-mesenchymal transition in thyroid carcinoma via targeting to miR-942-5p/TWIST1 signaling pathway.
Wang T; Huang Y
J Bioenerg Biomembr; 2021 Oct; 53(5):609-620. PubMed ID: 34164767
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-183-5p contributes to malignant progression through targeting PDCD4 in human hepatocellular carcinoma.
Duan X; Li W; Hu P; Jiang B; Yang J; Zhou L; Mao X; Tian B
Biosci Rep; 2020 Oct; 40(10):. PubMed ID: 33078826
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-486-5p, which is downregulated in hepatocellular carcinoma, suppresses tumor growth by targeting PIK3R1.
Huang XP; Hou J; Shen XY; Huang CY; Zhang XH; Xie YA; Luo XL
FEBS J; 2015 Feb; 282(3):579-94. PubMed ID: 25475121
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-361-5p suppresses the tumorigenesis of hepatocellular carcinoma through targeting WT1 and suppressing WNT/β-cadherin pathway.
Cheng Y; Qiu L; He GL; Cai L; Peng BJ; Cao YL; Pan MX
Eur Rev Med Pharmacol Sci; 2019 Oct; 23(20):8823-8832. PubMed ID: 31696469
[TBL] [Abstract][Full Text] [Related]
15. Role of miR-16-5p in the proliferation and metastasis of hepatocellular carcinoma.
Cheng B; Ding F; Huang CY; Xiao H; Fei FY; Li J
Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):137-145. PubMed ID: 30657555
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-98-5p Inhibits Tumorigenesis of Hepatitis B Virus-Related Hepatocellular Carcinoma by Targeting NF-κB-Inducing Kinase.
Fei X; Zhang P; Pan Y; Liu Y
Yonsei Med J; 2020 Jun; 61(6):460-470. PubMed ID: 32469170
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-424-5p acts as a potential biomarker and inhibits proliferation and invasion in hepatocellular carcinoma by targeting TRIM29.
Du H; Xu Q; Xiao S; Wu Z; Gong J; Liu C; Ren G; Wu H
Life Sci; 2019 May; 224():1-11. PubMed ID: 30876939
[TBL] [Abstract][Full Text] [Related]
18. miR-326 regulates EMT and metastasis of endometrial cancer through targeting TWIST1.
Liu W; Zhang B; Xu N; Wang MJ; Liu Q
Eur Rev Med Pharmacol Sci; 2017 Oct; 21(17):3787-3793. PubMed ID: 28975990
[TBL] [Abstract][Full Text] [Related]
19. Promotion of hepatocellular carcinoma metastasis through matrix metalloproteinase activation by epithelial-mesenchymal transition regulator Twist1.
Zhao XL; Sun T; Che N; Sun D; Zhao N; Dong XY; Gu Q; Yao Z; Sun BC
J Cell Mol Med; 2011 Mar; 15(3):691-700. PubMed ID: 20219012
[TBL] [Abstract][Full Text] [Related]
20. MiR-199a-5p suppresses tumorigenesis by targeting clathrin heavy chain in hepatocellular carcinoma.
Huang GH; Shan H; Li D; Zhou B; Pang PF
Cell Biochem Funct; 2017 Mar; 35(2):98-104. PubMed ID: 28261837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]